2013 Perspectives In Rheumatic Diseases Conference Highlights CME Post Test

Reviewed by Editorial Team

The ProProfs editorial team is comprised of experienced subject matter experts. They've collectively created over 10,000 quizzes and lessons, serving over 100 million users. Our team includes in-house content moderators and subject matter experts, as well as a global network of rigorously trained contributors. All adhere to our comprehensive editorial guidelines, ensuring the delivery of high-quality content.

Learn about Our Editorial Process

| By Chse

Chse

Community Contributor

Quizzes Created: 1 | Total Attempts: 226

| Attempts: 226

Questions

Feedback

During the Quiz End of Quiz

Difficulty

Easy First Hard First Sequential

Share on Facebook Share on Twitter Share on Whatsapp Share on Pinterest Share on Email Copy to Clipboard Embed on your website

1/8 Questions

The concept of treating to target began to emerge as an accepted clinical strategy following publication of:
- A. The ACR EULAR classification criteria
- B. The ADACTA (ADalamumab ACTemrA) study
- C. The Clinical Disease Activity Index (CDAI)
- D. The Tight Control for Rheumatoid Arthritis (TICORA) trial

About This Quiz

This post-test assesses key insights from the 2013 Perspectives in Rheumatic Diseases Conference, focusing on advancements in rheumatoid arthritis management, including diagnostic criteria, treatment strategies, and comparative studies of biologic agents.

2013 Perspectives In Rheumatic Diseases Conference Highlights CME Post Test - Quiz

2.

The GRAPPA approach has demonstrated that ________ is the class of drugs that has been shown to affect the status of all five domains of psoriatic arthritis.
- A. Anti-tumor necrosis factor agents
- B. Biologics
- C. Interleukins
- D. JAK inhibitors
Correct Answer

A. A. Anti-tumor necrosis factor agents

Explanation

The GRAPPA approach has demonstrated that anti-tumor necrosis factor agents are the class of drugs that has been shown to affect the status of all five domains of psoriatic arthritis. This suggests that these agents have a broad impact on the disease and can effectively target multiple aspects of psoriatic arthritis.

Rate this question:
3.

In patients with psoriasis, numerous studies have demonstrated that tumor necrosis factor inhibitors have demonstrated therapeutic synergy with ________.
- A. Interleukin-12/23 inhibitors
- B. Methotrexate
- C. Systemic corticosteroids
- D. Vitamin D analogs
Correct Answer

A. B. Methotrexate

Explanation

Numerous studies have shown that tumor necrosis factor inhibitors have therapeutic synergy with Methotrexate in patients with psoriasis. Methotrexate is an immunosuppressive medication that helps to reduce inflammation and slow down the growth of skin cells. When used in combination with tumor necrosis factor inhibitors, it can enhance the effectiveness of the treatment and provide better outcomes for patients with psoriasis.

Rate this question:
4.
1. More than ___% of patients with rheumatoid arthritis have radiographic abnormalities within 2 years of diagnosis.
- 60%
- 70%
- 80%
- 90%
Correct Answer

A. 90%

Explanation

Within 2 years of diagnosis, it is reported that more than 90% of patients with rheumatoid arthritis have radiographic abnormalities. This suggests that the majority of individuals with rheumatoid arthritis experience changes in their joints that can be detected through imaging techniques such as X-rays. These abnormalities may include joint erosion, narrowing of joint spaces, and the formation of bone spurs. This high percentage highlights the progressive nature of the disease and the importance of early detection and intervention to prevent further joint damage.

Rate this question:
5.

According to the ACR/EULAR classification criteria published in 2010, a diagnosis of “definite RA” is indicated by a score of ___ or more out of a possible 10.
- 2
- 4
- 6
- 8
Correct Answer

A. 6

Explanation

According to the ACR/EULAR classification criteria published in 2010, a diagnosis of "definite RA" is indicated by a score of 6 or more out of a possible 10.

Rate this question:
6.

Which one of the following assessment tools relies entirely on patient-reported data?
- A. Clinical Disease Activity Index (CDAI)
- B. Disease Activity Score
- C. Routine Assessment of Patient Index Data (RAPID)-3
- D. Simplified Disease Activity Index (SDAI)
Correct Answer

A. C. Routine Assessment of Patient Index Data (RAPID)-3

Explanation

The correct answer is C. Routine Assessment of Patient Index Data (RAPID)-3. This assessment tool relies entirely on patient-reported data because it is designed to measure the impact of rheumatoid arthritis on patients' physical function, pain, and global health. It does not include any objective measures or clinician assessments.

Rate this question:
7.

The use of TNF inhibitors in ______ is complicated by a lack of supporting data in controlled clinical trials.
- A. Elderly patients
- B. Patients with comorbid conditions
- C. Pediatric patients
- D. Psoriasis
Correct Answer

A. C. Pediatric patients

Explanation

The use of TNF inhibitors in pediatric patients is complicated by a lack of supporting data in controlled clinical trials. This means that there is not enough scientific evidence from well-designed studies to determine the safety and effectiveness of TNF inhibitors in treating pediatric patients. Therefore, healthcare providers may be hesitant to prescribe these medications to children due to the lack of data supporting their use in this population.

Rate this question:
8.

_____ is the first trial to compare two biologic agents in patients with rheumatoid arthritis who had not responded adequately to methotrexate.
- A. The ADACTA study
- B. The AMPLE study
- C. The MDA study
- D. The TICORA trial
Correct Answer

A. B. The AMPLE study

Explanation

The AMPLE study is the first trial to compare two biologic agents in patients with rheumatoid arthritis who had not responded adequately to methotrexate.

Rate this question:

Quiz Review Timeline (Updated): Mar 15, 2023 +

Our quizzes are rigorously reviewed, monitored and continuously updated by our expert board to maintain accuracy, relevance, and timeliness.

Current Version
Mar 15, 2023

Quiz Edited by
ProProfs Editorial Team
Jan 25, 2013

Quiz Created by
Chse

2013 Perspectives In Rheumatic Diseases Conference Highlights CME Post Test

The concept of treating to target began to emerge as an accepted clinical strategy following publication of:

Quiz Preview

The GRAPPA approach has demonstrated that ________ is the class of drugs that has been shown to affect the status of all five domains of psoriatic arthritis.

In patients with psoriasis, numerous studies have demonstrated that tumor necrosis factor inhibitors have demonstrated therapeutic synergy with ________.

More than ___% of patients with rheumatoid arthritis have radiographic abnormalities within 2 years of diagnosis.

According to the ACR/EULAR classification criteria published in 2010, a diagnosis of “definite RA” is indicated by a score of ___ or more out of a possible 10.

Which one of the following assessment tools relies entirely on patient-reported data?

The use of TNF inhibitors in ______ is complicated by a lack of supporting data in controlled clinical trials.

_____ is the first trial to compare two biologic agents in patients with rheumatoid arthritis who had not responded adequately to methotrexate.